Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effect of booster vaccination against Delta and Omicron variants in Iceland

Gudmundur L Norddahl, Pall Melsted, Kristbjorg Gunnarsdottir, Gisli H Halldorsson, Thorunn A Olafsdottir, Arnaldur Gylfason, Mar Kristjansson, Olafur T Magnusson, Patrick Sulem, Daniel F Gudbjartsson, Unnur Thorsteinsdottir, Ingileif Jonsdottir, Kari Stefansson
doi: https://doi.org/10.1101/2022.02.26.22271509
Gudmundur L Norddahl
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pall Melsted
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
2School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pall.melsted@decode.is
Kristbjorg Gunnarsdottir
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisli H Halldorsson
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thorunn A Olafsdottir
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnaldur Gylfason
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mar Kristjansson
3Internal Medicine and Rehabilitation Services, Landspitali – The National University Hospital of Iceland Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olafur T Magnusson
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Sulem
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel F Gudbjartsson
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
2School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Unnur Thorsteinsdottir
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
4Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingileif Jonsdottir
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
4Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari Stefansson
1deCODE genetics/Amgen, Inc., Reykjavik, Iceland
4Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

By the end of July 2021, the majority of the Icelandic population had received vaccination against COVID-19. In mid-July a wave of SARS-CoV-2 infections, dominated by the delta variant, spread through the population, followed by an omicron wave in December. A booster vaccination campaign was initiated to curb the spread of the virus. We estimated the risk of infection for different vaccine combinations using vaccination data from 276,028 persons and 963,557 qPCR tests for 277,687 persons. We measured anti-Spike-RBD antibody levels and ACE2-Spike binding inhibitory activity in 371 persons who received one of four recommended vaccination schedules with or without an mRNA vaccine booster. Overall, we found different antibody levels and inhibitory activity between recommended vaccination schedules, which was reflected in the observed risk of SARS-CoV-2 infections. We observed an increased protection following mRNA boosters, against both omicron and delta variant infections, although BNT162b2 boosters provided greater protection against omicron than mRNA-1273 boosters.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the National Bioethics Committee of Iceland (approval no. VSN-21-072), after review by the Icelandic Data Protection Authority (DPA). Participants who donated blood signed informed consent. The personal identities of participants were encrypted using a third-party system approved and monitored by the DPA.The study was approved by the National Bioethics Committee of Iceland (approval no. VSN-21-072), after review by the Icelandic Data Protection Authority (DPA). Participants who donated blood signed informed consent. The personal identities of participants were encrypted using a third-party system approved and monitored by the DPA.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All sequences used in this analysis will be made available in the European Nucleotide Archive (ENA) under accession number PRJEB44803 (https://www.ebi.ac.uk/ena/browser/view/PRJEB44803)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 01, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effect of booster vaccination against Delta and Omicron variants in Iceland
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of booster vaccination against Delta and Omicron variants in Iceland
Gudmundur L Norddahl, Pall Melsted, Kristbjorg Gunnarsdottir, Gisli H Halldorsson, Thorunn A Olafsdottir, Arnaldur Gylfason, Mar Kristjansson, Olafur T Magnusson, Patrick Sulem, Daniel F Gudbjartsson, Unnur Thorsteinsdottir, Ingileif Jonsdottir, Kari Stefansson
medRxiv 2022.02.26.22271509; doi: https://doi.org/10.1101/2022.02.26.22271509
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effect of booster vaccination against Delta and Omicron variants in Iceland
Gudmundur L Norddahl, Pall Melsted, Kristbjorg Gunnarsdottir, Gisli H Halldorsson, Thorunn A Olafsdottir, Arnaldur Gylfason, Mar Kristjansson, Olafur T Magnusson, Patrick Sulem, Daniel F Gudbjartsson, Unnur Thorsteinsdottir, Ingileif Jonsdottir, Kari Stefansson
medRxiv 2022.02.26.22271509; doi: https://doi.org/10.1101/2022.02.26.22271509

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)